Harbour Investments’s Co-Diagnostics CODX Stock Holding History

Harbour Investments’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4	Buy	+2	New	+$7	﹤0.01%	4653
2024 Q1	–	Hold	0	–	-$13	–	3230
2023 Q4	–	Hold	0	–	–	–	3113
2023 Q3	–	Hold	0	–	–	–	2976
2023 Q2	–	Hold	0	–	–	–	3010
2023 Q1	–	Hold	0	–	–	–	2980
2022 Q4	–	Hold	0	–	–	–	2973
2022 Q3	–	Hold	0	–	–	–	2735
2022 Q2	–	Hold	0	–	–	–	2735
2021 Q4	–	Sell	-17	Closed	-$4.46K	–	2818
2021 Q3	$5K	Hold	17	–	–	﹤0.01%	2966
2021 Q2	$4K	Hold	17	–	–	﹤0.01%	3127
2021 Q1	$5K	Buy	+17	New	+$6.79K	﹤0.01%	2891

Other funds holding CODX

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAM

Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HWA

Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Harbour Investments's CODX Position: Q1 2026 in Review

Harbour Investments opened a new position in Co-Diagnostics (CODX) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #4653 among its holdings. This is a return to the name: Harbour Investments previously reported a position in CODX as recently as Q3 2021.

Harbour Investments first reported a position in CODX in Q1 2021 and has held it in 4 quarters since. The position peaked at $5K in Q3 2021. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

Harbour Investments held 2 shares of Co-Diagnostics worth $4 as of Q1 2026.
Co-Diagnostics was a new Harbour Investments position in Q1 2026.
Co-Diagnostics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4653 holding.
Harbour Investments first reported a position in Co-Diagnostics in Q1 2021 and has held it in 4 quarters since.
Harbour Investments's Co-Diagnostics position peaked at $5K in Q3 2021.
14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.